 | Up a level |
Sathekge, Mike M; Lawal, Ismaheel O; Bal, Chandrasekhar; Bruchertseifer, Frank; Ballal, Sajana; Cardaci, Giuseppe; Davis, Cindy; Eiber, Mathias; Hekimsoy, Türkay; Knoesen, Otto; Kratochwil, Clemens; Lenzo, Nat P; Mahapane, Johncy; Maserumule, Letjie C; Mdlophane, Amanda H; Mokoala, Kgomotso M G; Ndlovu, Honest; Pant, Vineet; Rathke, Hendrik; Reed, Janet; ... (2024). Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study. The Lancet. Oncology, 25(2), pp. 175-183. Elsevier 10.1016/S1470-2045(23)00638-1
Baum, Richard P.; Singh, Aviral; Benešová, Martina; Vermeulen, Christiaan; Gnesin, Silvano; Köster, Ulli; Johnston, Karl; Müller, Dirk; Senftleben, Stefan; Kulkarni, Harshad R.; Türler, Andreas; Schibli, Roger; Prior, John O.; van der Meulen, Nicholas P.; Müller, Cristina (2017). Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with 152 Tb-DOTATOC. Dalton transactions, 46(42), pp. 14638-14646. Royal Society of Chemistry 10.1039/C7DT01936J
Singh, Aviral; van der Meulen, Nicholas P.; Müller, Cristina; Klette, Ingo; Kulkarni, Harshad R.; Türler, Andreas; Schibli, Roger; Baum, Richard P. (2017). First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced 44 Sc-DOTATOC: A Proof-of-Concept Study. Cancer biotherapy and radiopharmaceuticals, 32(4), pp. 124-132. Mary Ann Liebert 10.1089/cbr.2016.2173
